Article
Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.
The Journal of experimental medicine - 1 Apr 1993
Racioppi L, Ronchese F, Matis L A, Germain R N
Abstract excerpt
Clonal activation of CD4+ and CD8+ T lymphocytes depends on binding of peptide-major histocompatibility complex (MHC) molecule complexes by their alpha/beta receptors, eventually resulting in sufficient aggregation to initiate second messenger generation. The nature of intracellular signals resulting from such T cell receptor (TCR) occupancy is believed to be independent of the specific structure of the ligand...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
